Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising plans through debt or equity in the transcript. The company currently has total borrowings of approximately Rs. 225 crores as of 30th June, including Rs. 41 crores of term loans. The management discussed relooking and recalibrating CAPEX plans due to challenges in some divisions but did not mention raising funds via new debt or equity. They are focused on optimizing existing investments and CAPEX to maximize productivity with minimal additional investment. No direct references were made to plans for new debt issuance or equity f

Any current/future capex/capital investment/strategic investment?

Mahad Phase-I single product plant is progressing well and remains on track, part of their specialty aroma segment. Hydrogenation facility under construction; investment of ~Rs. 45 crores done, with Rs. 90-100 crores pending. Recalibration of CAPEX plans ongoing, particularly for plants other than Mahad Phase-I, to optimize investments and improve productivity. Certain CAPEX projects near launch are being reconsidered due to subdued demand and pricing challenges; some products planned for new plants have found a place in existing plants. Future CAPEX decisions will be based on market condition

Future growth expectations in sales/revenue/volumes?

The fragrance and flavor division is showing very strong growth, driven by new wins across geographies and with one of the largest FMCG companies in India. Top line guidance aims to at least reach last year's numbers with potential for growth, but the overall revenue faces challenges primarily due to subdued demand and pricing pressure in the camphor and terpene chemicals division. Volume growth in specialty aroma ingredients is stable, while camphor and terpene chemicals volumes have declined QoQ due to seasonality and production shutdowns. The company remains committed to strengthening its m

Future growth expectations in earnings/operating earnings/profits/EPS?

Company expects strong growth in fragrance and flavor division supported by new wins and reduction in input costs. Camphor and terpene chemicals division faces demand and pricing pressure impacting overall profitability. Management is monitoring market conditions closely due to fluid business environment. Guidance maintained to at least match last year's top line, with bottom line clarity expected in coming quarters. Challenges include subdued demand, pricing pressures, and competitive landscape, especially from China. Specialty aroma ingredients face global challenges but product development

Current/ Expected Orderbook/ Pending Orders?

The company did not disclose specific details about the size of the significant order win from the last quarter, citing contractual confidentiality. It was confirmed that this order is part of a long-term contract. Some CAPEX projects nearing completion and ready for sending samples to customers have been repurposed; products planned for these projects are being accommodated within existing plants instead. No explicit information was shared on an exact current order book size or the value of pending orders. Management indicated they would provide future updates regarding CAPEX recalibration an

Oriental Aromat.Q1 FY24Chemicals & Petrochemicals

Oriental Aromat. Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹532P/E: 337.6Market Cap: ₹1.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 4

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The fragrance and flavor division is showing very strong growth, driven by new wins across geographies and with one of the largest FMCG companies in India.
Top line guidance aims to at least reach last year's numbers with potential for growth, but the overall revenue faces challenges primarily due to subdued demand and pricing pressure in the camphor and terpene chemicals division.
Volume growth in specialty aroma ingredients is stable, while camphor and terpene chemicals volumes have declined QoQ due to seasonality and production shutdowns.
The company remains committed to strengthening its market position and innovation pipeline, expecting healthy growth in fragrance and flavor segments.
Macro challenges such as Chinese competition and global destocking create a fluid demand environment.
CAPEX recalibration may optimize future productivity aligning with market demand.
Overall, the outlook is cautiously optimistic with focus on fragrance and flavor growth balancing pressures in other segments.

Margin guidance

Category 4

Company expects strong growth in fragrance and flavor division supported by new wins and reduction in input costs.
Camphor and terpene chemicals division faces demand and pricing pressure impacting overall profitability.
Management is monitoring market conditions closely due to fluid business environment.
Guidance maintained to at least match last year's top line, with bottom line clarity expected in coming quarters.
Challenges include subdued demand, pricing pressures, and competitive landscape, especially from China.
Specialty aroma ingredients face global challenges but product development plans remain on track.
CAPEX plans under review to optimize investments amid market uncertainties.
No clear timeline for market normalization given external macroeconomic challenges.
Earnings visibility expected to improve over the next few quarters as market dynamics stabilize.

See what Oriental Aromat. management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or future fundraising plans through debt or equity in the transcript.
The company currently has total borrowings of approximately Rs. 225 crores as of 30th June, including Rs. 41 crores of term loans.
The management discussed relooking and recalibrating CAPEX plans due to challenges in some divisions but did not mention raising funds via new debt or equity.
They are focused on optimizing existing investments and CAPEX to maximize productivity with minimal additional investment.
No direct references were made to plans for new debt issuance or equity fundraising during the call.

Order book

The company did not disclose specific details about the size of the significant order win from the last quarter, citing contractual confidentiality.
It was confirmed that this order is part of a long-term contract.
Some CAPEX projects nearing completion and ready for sending samples to customers have been repurposed; products planned for these projects are being accommodated within existing plants instead.
No explicit information was shared on an exact current order book size or the value of pending orders.
Management indicated they would provide future updates regarding CAPEX recalibration and utilization in upcoming earnings calls.
Overall, details on orderbooks remain guarded due to confidentiality and strategic considerations.

See what Oriental Aromat. management said on order book — free account, 30 seconds.

Capex plans

Yes

Mahad Phase-I single product plant is progressing well and remains on track, part of their specialty aroma segment.
Hydrogenation facility under construction; investment of ~Rs. 45 crores done, with Rs. 90-100 crores pending.
Recalibration of CAPEX plans ongoing, particularly for plants other than Mahad Phase-I, to optimize investments and improve productivity.
Certain CAPEX projects near launch are being reconsidered due to subdued demand and pricing challenges; some products planned for new plants have found a place in existing plants.
Future CAPEX decisions will be based on market conditions and long-term viability; updates to be shared in forthcoming earnings calls.
Company is cautious due to pricing pressure in camphor and terpene chemicals and aggressive competition from Chinese manufacturers.

Track Oriental Aromat. — get its next earnings analysis in your feed

How does Oriental Aromat. rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisOriental Aromat.

Rev 3Mar 4

See where Oriental Aromat. sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Oriental Aromat. rank in Chemicals & Petrochemicals?

Compare Oriental Aromat. against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Oriental Aromat.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →